GLOBALT Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4M Sell
14,538
-277
-2% -$283K 0.59% 26
2026
Q1
$13.6M Buy
14,815
+394
+3% +$399K 0.49% 27
2025
Q4
$15.5M Buy
14,421
+1,760
+14% +$1.68M 0.57% 27
2025
Q3
$9.66M Sell
12,661
-264
-2% -$196K 0.35% 38
2025
Q2
$10.1M Sell
12,925
-2,364
-15% -$1.84M 0.39% 33
2025
Q1
$12.6M Sell
15,289
-444
-3% -$369K 0.52% 25
2024
Q4
$12.1M Sell
15,733
-4,292
-21% -$3.55M 0.47% 27
2024
Q3
$17.7M Sell
20,025
-1,051
-5% -$945K 0.66% 21
2024
Q2
$19.1M Sell
21,076
-392
-2% -$314K 0.76% 22
2024
Q1
$16.7M Sell
21,468
-1,345
-6% -$957K 0.66% 22
2023
Q4
$13.3M Buy
+22,813
New +$13.3M 0.55% 22

Other funds holding LLY

GLOBALT Investments's LLY Position: Q2 2026 in Review

GLOBALT Investments reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $283K and leaving 14,538 shares worth $17.4M. The position accounts for 0.59% of the portfolio, ranked #26.

GLOBALT Investments first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.1M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GLOBALT Investments held 14,538 shares of Eli Lilly worth $17.4M as of Q2 2026.
  • GLOBALT Investments sold 277 Eli Lilly shares in Q2 2026, an estimated $283K.
  • Eli Lilly made up 0.59% of GLOBALT Investments's portfolio in Q2 2026, its #26 holding.
  • GLOBALT Investments first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • GLOBALT Investments's Eli Lilly position peaked at $19.1M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.